en · de · es · fr · pt
tb-500-notes.peptides7501.com › Faq › Identity And Research Background — Hands-On Walkthrough

Identity And Research Background — Hands-On Walkthrough

By Editorial Desk · published 2025-11-24 · last reviewed 2025-12-10 · Faq

lyophilised powder comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2025-12-10. Numbers and descriptions here follow the published literature rather than marketing material.

Identity and Research Background

Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.

TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.

TB-500 Background and Identity

The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.

Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.

TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.

Tb-500 at a glance

PropertyValueNotes
Molecular formulaC38H68N10O14Acetylated heptapeptide form
Monoisotopic mass888.5 DaAverage mass about 889 Da
AppearanceWhite to off-white solidUsually supplied as lyophilised powder
Solubility classHighly water solubleAlso dissolves in aqueous buffers
Common synonymsTbeta4 fragment, thymosin beta-4 (17-23)Refer to the same sequence

Detection, Stability, and Regulatory Status

Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.

Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.

Related pages on this site

Research Framing and Evidence Base

Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.

Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.

Handling, Storage, and Quality Control

Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.

Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.

Background from the literature

A gene is a sequence of DNA that contains genetic information and can influence the phenotype of an organism. Within a gene, the sequence of bases along a DNA strand defines a messenger RNA sequence, which then defines one or more protein sequences. The relationship between the nucleotide sequences of genes and the amino-acid sequences of proteins is determined by the rules of translation, known collectively as the genetic code. The genetic code consists of three-letter 'words' called codons formed from a sequence of three nucleotides (e.g., ACT, CAG, TTT). In transcription, the codons of a gene are copied into messenger RNA by RNA polymerase. This RNA copy is then decoded by a ribosome that reads the RNA sequence by base-pairing the messenger RNA to transfer RNA, which carries amino acids. Since there are 4 bases in 3-letter combinations, there are 64 possible codons (43 combinations). These encode the twenty standard amino acids, giving most amino acids more than one possible codon. There are also three 'stop' or 'nonsense' codons signifying the end of the coding region; these are the TAG, TAA, and TGA codons, (UAG, UAA, and UGA on the mRNA).

Mazda's automotive plans for the early sixties consisted of growing alongside the Japanese economy. To achieve this goal, they began by building an extremely affordable kei car, the R360 in 1960, planning on introducing gradually larger and pricier cars as the Japanese customers became able to afford them. As a preview, testing the waters, a larger "Mazda 700" prototype was shown at the eighth Tokyo Motor Show in 1961, and formed the basis for the upcoming Mazda Familia. Meanwhile, the four door version of the R360 was introduced as the Mazda Carol, which appeared in 1962, and discontinued in 1964. The first production Familia, styled by a young Giorgetto Giugiaro while working at Carrozzeria Bertone, appeared in October 1963. In line with Mazda's policy of only gradually approaching the production of private cars (a luxury in Japan at the time), the first Familia was initially only available as a commercial two-door wagon called the Familia van. The van was joined in April 1964 by a plusher Familia wagon, in October by a four-door saloon, and in November by a two-door saloon. The "flat deck" design of the saloon versions was reportedly inspired by the Chevrolet Corvair. Private car versions received foglights in the grille as well as more chrome trim. The Familia was sold in other markets as the 800. The Familia was introduced to the Japanese market in time for the 1964 Summer Olympics which began in October. The cars used a 782 cc, "SA" four-stroke aluminum straight-four engine, also known as the "white engine".

== Vector structure == In addition to the target gene, there are three important elements in a vector: an origin of replication, a selectable marker, and a multiple cloning site. An origin of replication is a DNA sequence that starts the process of DNA replication, allowing the vector to clone itself. A multiple cloning site contains binding sites for several restriction enzymes, making it easier to insert different DNA sequences into the vector. A selectable marker confers some trait that can be easily selected for in a host cell, so that it can be determined whether transformation was successful. The most common selectable markers are genes for antibiotic resistance, so that host cells without the construct will die off when exposed to the antibody and only host cells with the construct will remain.

=== Addiction and dependence liability === DMT, like other serotonergic psychedelics, is considered to be non-addictive with low abuse potential. A study examining substance use disorder for the DSM-IV reported that almost no hallucinogens produced dependence, unlike psychoactive drugs of other classes such as stimulants and depressants. At present, there have been no studies that report drug withdrawal syndrome with termination of DMT, and dependence potential of DMT and the risk of sustained psychological disturbance may be minimal when used infrequently; however, the physiological dependence potential of DMT and ayahuasca has not yet been documented convincingly.

Sources: en.wikipedia.org

Reference notes

Darshan Ranganathan (4 June 1941 – 4 June 2001) was an organic chemist from India who was known for her work in bio-organic chemistry, including "pioneering work in protein folding." She was also recognized for her work in "supramolecular assemblies, molecular design, chemical simulation of key biological processes, synthesis of functional hybrid peptides and synthesis of nanotubes."

Partial agonism and signaling bias describe distinct pharmacological properties: partial agonism refers to the maximum response produced relative to a reference full agonist, whereas signaling bias describes the relative preference for different intracellular signaling pathways activated by the same receptor. Activation of MOR primarily couples the receptor to inhibitory Gi/o proteins, resulting in inhibition of adenylyl cyclase, reduced intracellular cyclic AMP (cAMP), modulation of potassium and calcium channels, and decreased neuronal excitability and neurotransmitter release. β-Arrestin recruitment represents a partially distinct signaling and regulatory pathway involved in receptor desensitization, trafficking, and internalization. Consequently, a ligand may display partial efficacy for G-protein signaling while producing substantially weaker β-arrestin recruitment. MORs may also form receptor homomers containing more than one receptor protomer. Therefor occupancy of one protomer by a partial agonist does not necessarily prevent a second ligand from occupying the other orthosteric binding site of the second protomer. Thus, a 48%-efficacy partial agonist and a second partial agonist exhibiting 66% efficacy would occupy the second separate protomer within the same receptor complex. Buprenorphine was patented in 1965, FDA approved for medical use as an analgesic in 1981, and FDA approved for treating opioid use disorder in 2002. It is on the World Health Organization's List of Essential Medicines.

Cyclophosphamide (Cytoxan, Procytox), Doxorubicin (Adriamycin) and Vincristine (Oncovin) Paclitaxel (Taxol) Irinotecan (Camptosar) Guidelines recommended as of 2018 that patients who relapse > 6 months from initial therapy should be retreated with the original chemotherapy regimen. For patients who relapse in < 6 months, single-agent chemotherapy either topotecan second-line therapy, or paclitaxel can be used.

Arsenic (III) binding sites usually use thiol groups of cysteine residues. The catalysis involves thiolates of Cys72, Cys174, and Cys224. In an SN2 reaction, the positive charge on the SAM sulfur atom pulls the bonding electron from the carbon of the methyl group, which interacts with the arsenic lone pair to form an As−C bond, leaving SAH.

In early 1984, just after South Africa and Angola had agreed to the principles of a peace settlement, UNITA had seized the opportunity to issue its own demanding conditions under which it would also accept the terms of a ceasefire. Savimbi requested a government of national unity with the MPLA in which he was granted a part, and threatened to begin attacking major cities if he was ignored. In this manner Savimbi sought to interlace conditionality over an SADF and FAPLA disengagement with his own conflict of interests with the Angolan regime. Although Botha approved of UNITA as an ostensibly anti-communist movement, he did nothing to impress Savimbi's demands on dos Santos. UNITA responded by raiding Sumbe, a settlement two hundred and sixty kilometres to the south of Luanda. That June, UNITA sabotaged the oil pipeline in Cabinda, kidnapping 16 British expatriate workers and a Portuguese technician. Six months later the insurgents raided Cafunfo, killing 100 FAPLA personnel. Most of these attacks were planned and executed from Jamba, a town in Cuando Cubango Province, which Savimbi had proclaimed UNITA's new national headquarters. Jamba had no prior strategic significance, possessed no agricultural base, and had limited access to fresh water, but it was located as far away from FAPLA bases as possible and within easy reach of SADF bases in Ovamboland and the Caprivi Strip. FAPLA had deserted the region for precisely this reason, withdrawing north after Operation Protea, but in the process left behind a power vacuum which Savimbi was quick to exploit.

Sources: en.wikipedia.org

Reference notes

One of the most acutely toxic indoor air contaminants is carbon monoxide (CO), a colorless and odorless gas that is a by-product of incomplete combustion. Carbon monoxide may be emitted from tobacco smoke and generated from malfunctioning fuel burning stoves (wood, kerosene, natural gas, propane) and fuel burning heating systems (wood, oil, natural gas) and from blocked flues connected to these appliances. In developed countries the main sources of indoor CO emission come from cooking and heating devices that burn fossil fuels and are faulty, incorrectly installed or poorly maintained. Appliance malfunction may be due to faulty installation or lack of maintenance and proper use. In low- and middle-income countries the most common sources of CO in homes are burning biomass fuels and cigarette smoke. Health effects of CO poisoning may be acute or chronic and can occur unintentionally or intentionally (self-harm). By depriving the brain of oxygen, acute exposure to carbon monoxide may have effects on the neurological system (headache, nausea, dizziness, alteration in consciousness and subjective weakness), the cardiovascular and respiratory systems (myocardial infarction, shortness of breath, or rapid breathing, respiratory failure). Acute exposure can also lead to long-term neurological effects such as cognitive and behavioral changes. Severe CO poisoning may lead to unconsciousness, coma and death. Chronic exposure to low concentrations of carbon monoxide may lead to lethargy, headaches, nausea, flu-like symptoms and neuropsychological and cardiovascular issues.

==== Pressure on the legal profession ==== A group of 90 lawyers from Hebei, Henan and Shandong—the three worst affected provinces—had made pro bono offers to assist victims, and a list of their names was published. Organisers of the group declared that they had come under pressure from officials to not get involved in the issue. The Beijing Lawyers' Association, a part of the Communist Party apparatus, asked its members "to put faith in the party and government". Other members of the group have reportedly received less subtle requests. Authorities are said to fear social unrest if lawsuits were unleashed. Pro-Beijing Hong Kong journal Ta Kung Pao reported that central authorities, fearful of the effect of mass lawsuits, held a meeting with lawyers' groups on 14 September, asking them to "act together, and help maintain stability". Chang Boyang, one of the group of volunteer lawyers, said he had filed one suit in Guangdong against Sanlu on behalf of the parents of one victim, and another suit in Henan. According to Chang, the justice department of Henan ordered 14 Henan lawyers to drop their cases and "follow the arrangements set out by the government". He said they were told that if they did not, "the lawyer and the firm will be dealt with." Zhang Yuanxin, lawyer and officer in the Xinjiang Lawyers' Association said that these government actions have "set back the development of the legal profession," and called this interference in citizen lawsuits "intolerable".

Baseball Digest All-Star Rookie Team (1998) Associated Press MLB All-Star Team (2000) Baseball Digest MLB Player of the Year (2000) USA Baseball Alumni Player of the Year (2000) Achievements National League (NL) Batting Champion (2000) NL slugging percentage leader (2000) NL RBI leader (2000) NL Doubles leader (2000, Helton hit 59 doubles during the season, which tied Chuck Klein for the third-highest single-season doubles total in NL history.) Hit for the cycle (June 19, 1999) Percentage triple crown (2000) NL hits leader (2000) NL on-base percentage leader (2000, 2005, 2007) NL total bases leader (2000) NL extra base hits leader (2000) Colorado Rockies career leader in games played (2,247), at bats (7,962), runs (1,401), hits (2,519), total bases (4,292), doubles (592), home runs (369), RBI (1,406), walks (1,335), and intentional walks (185). Colorado Rockies retired Helton's number 17 on August 17, 2014. Helton first appeared on the National Baseball Hall of Fame ballot in 2019, when he received 16.5% of the vote, well short of the 75% required for election, but above the 5% minimum required to remain on the ballot. On January 23, 2024, Helton was elected to the Hall of Fame, receiving 79.7% of the vote. He is the second Rockies player, after Larry Walker, to be elected. Helton was formally inducted on July 21, 2024.

Although the party's ideology has shifted throughout its existence, it has consistently presented itself through a Christian democratic and politically Catholic profile. It was seen to occupy the political centre, although the party is considered to have shifted towards the right of centre in early 1930s under the leadership of Ludwig Kaas. The Oxford Handbook of the Weimar Republic argues that while "Until recently, historians considered Kaas to have been an... ominous indication of the Centre’s shift to the right", the party's position was "more nuanced", as it continued to accept the legitimacy of the Weimar Republic and its constitution, and Kaas strove to reconcile both the left-leaning and right-leaning wings of the party. The party adopted a new program in 2008 in which it stated rejection for the traditional left and right divide of politics and called for a "value-oriented" platform guided by the principles of Christianity and Basic Law for the Federal Republic of Germany. The party supports the traditional family unit and is generally opposed to abortion. It has given support to right to life movements in Germany. During the Weimar era, the Centre Party was socially and economically heterogenous and included groups of various political views and interests, including republicans and monarchists. It represented the entire "political microcosm of Weimar Catholic society".

Sources: en.wikipedia.org

Frequently asked questions

Is TB-500 the same as thymosin beta-4?

No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.

What amino acids make up this peptide?

It consists of leucine, lysine, lysine, threonine, glutamic acid, threonine, and glutamine in that order. The N-terminal leucine is usually acetylated in the forms described in catalogues.

How much human data exists for this sequence?

Controlled human data is limited, and most published findings come from cell culture or animal work. This makes it difficult to state clinical effects with confidence.

What is TB-500?

TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.

Network